Response to infusion of noradrenalin and dobutamine during head up tilt in cardiovascular autonomic dysfunction in patients with neurodegenerative disorder.

Response to infusion of noradrenalin and dobutamine during head up tilt in cardiovascular autonomic dysfunction in patients with neurodegenerative disorder. - Response to infusion of noradrenalin and dobutamine during head up tilt in cardiovascular autonomic dysfunction in patients with neurodegenerative disorder.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015026

Enrollment

Registered

2014-09-05

Start date

2014-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurodegenerating disease

Interventions

a low dose of norepinephrine and dobutamine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: neurodegenerating disease with autonomic dysfunction

Exclusion criteria

Exclusion criteria: Individuals with diabetes mellitus, any known heart disease, hypertension, Cussing syndrome, rheumatism, difficulty in blood drawing, or other neurological disorders were excluded.

Design outcomes

Primary

Measure	Time frame
changes in blood pressure, heart rate, peripheral resistance and cardio output during drug load	—

Countries

Japan

Contacts

Public ContactIto Mizuki

Nagoya University Graduate School of Medicine neurology

itohm@med.nagoya-u.ac.jp+81-52-744-2385

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026